Radiofrequency (RF) microneedling has become one of the most sought-after rejuvenation treatments over the past decade, and rightfully so. It improves texture, elasticity, scars, and overall skin quality with minimal downtime. In late 2024 and early 2025, the U.S. Food and Drug Administration (FDA) released updated statements addressing safety concerns and device classifications related to energy-based microneedling devices (FDA, 2024a; FDA, 2024b).
December 2025 L+A Report
Technology for Skin Longevity: The New Pathway for Lifelong Skin Vitality
Skin longevity isn’t just a wellness trend—it’s becoming the lens through which today’s medical and spa skincare professionals design treatment plans, choose technologies, and guide patients through their long-term skin health journeys. The new frontier of skincare is rooted in the understanding that when we improve cellular function, we improve everything: resilience, vibrancy, structure, and the skin’s ability to age slowly and gracefully.
These statements created a wave of confusion in the aesthetics community, particularly among clients and newer professionals. As someone who has worked with RF microneedling devices for 12 years and trained across multiple platforms, I want to break down exactly what was said in the FDA RF Microneedling warning, what it really means, and why, for seasoned and well-trained providers, none of this is new or surprising.
The FDA RF Microneedling Warning What Was Actually Said
1. RF Microneedling Is Classified as a Medical Device
The FDA clarified that RF microneedling devices are considered medical devices requiring appropriate clearance and labeling (FDA, 2024a). This is not news to experienced medical providers, but it was news to many consumers and spa-level aesthetic professionals.
2. Training, Settings, and Device Knowledge Are Critical for Safety
The FDA emphasized the potential risks of improper needle depth, RF intensity, and technique, noting that adverse outcomes can occur when the operator does not understand the technology (FDA, 2024b). Examples of risks named include:
- Burns
- Pigmentary changes
- Scarring
- Infection
- Unintended fat loss
3. Patient Selection Matters
The FDA highlighted the importance of using RF microneedling only on appropriate candidates and in appropriate anatomical areas (FDA, 2024b). These devices are not one setting fits all.
4. Providers Must Discuss Risks and Obtain Informed Consent
Clear communication, risk disclosure, and use of consent forms were emphasized, reinforcing that RF microneedling is a medical procedure, not a casual beauty treatment.
Dr. Krystal Briglia, L+A Medical + Wellness Contributor
Dr. Krystal Briglia of Triada Integrative Medicine + Wellness is a board-certified nurse practitioner specializing in aesthetic dermatology, integrative medicine, and wellness. She has an extensive and diverse background in healthcare, with over a decade of experience working in emergency, critical care, trauma, aesthetics, healthcare administration, and healthcare education. Krystal holds multiple board certifications, including family practice, emergency, and critical care. Her educational background includes two undergraduate degrees, a degree in health sciences, and a bachelor’s degree in nursing from the University of Delaware. She holds three graduate-level degrees, including a master’s degree in nursing leadership, a master’s degree in business administration, and completed her nurse practitioner education at the University of Massachusetts. In 2016, Krystal completed her clinical doctorate in nursing practice. Dr. Briglia is an entrepreneur and specializes in organizational process improvement. She is a Lean Six Sigma master black belt, a certified Six Sigma champion, and a certified Kaizen facilitator. She also has a passion for education and spent 6 years teaching health profession graduate-level courses. During that time, she held a lead faculty position and helped the university develop a family nurse practitioner program from inception to credentialing and first graduates. Read Full Bio
Why These FDA RF Microneedling Comments Are Not New to Experienced Providers
In many ways, the FDA statement reinforces what the most experienced medical professionals have known, practiced, and taught for years.
With over 12 years in the aesthetic medicine field, across multiple devices, platforms, and treatment philosophies, I can confidently say:
These warnings have always been standard in proper training.
Every RF microneedling training I have participated in or taught has included:
- How RF energy distributes through needles
- How depth affects dermal and subdermal structures
- How energy levels influence collagen remodeling
- How to avoid fat atrophy
- Risk factors for PIH in skin of color
- Contraindications and pre and post care
- How anatomical site changes require settings
Nothing stated contradicts what well-trained, licensed providers already incorporate daily.
The concern is not the technology. The concern is untrained providers using advanced devices outside their scope or education.
My Clinical Take: Education, Expertise, and Individualization Are Everything
RF microneedling is safe, effective, and transformative when done correctly. But its safety hinges on the knowledge and competency of the person holding the device.
Here are the pillars of safe and effective RF microneedling, based on clinical experience:
1. Deep Understanding of Device Technology
Every Radiofrequency device is different.
They vary in:
- RF delivery (bipolar, monopolar, insulated vs. non-insulated needles)
- Needle length and precision
- Depth control accuracy
- Energy distribution patterns
Providers must be thoroughly trained on their specific device, not just on RF microneedling in general.
2. Appropriate Patient Selection
Not every patient is a candidate.
Considerations include:
- Fitzpatrick type
- Skin barrier health
- History of scarring or PIH
- Autoimmune or inflammatory skin conditions
- Anatomical location (for example, temples, forehead, and periorbital regions require different strategy)
3. Customized Rather than Cookie Cutter Treatment Plans
RF microneedling is not a three pass, same settings for everyone procedure.
Each patient requires:
- Individualized settings
- Tailored depth
- Appropriate energy
- Combined modalities when indicated
- Discussion of alternative technologies (for example, CO₂, IPL, RF tightening devices)
The best outcomes are achieved through personalization, not protocols that ignore patient variability.
4. Comprehensive Risk Discussion and Informed Consent
Patients should be aware of:
- Expected healing
- Possible adverse events
- Long-term considerations
- How other treatments may complement or conflict
This builds trust, sets expectations, and protects both patient and provider.
Why Education Protects Both Patients and the Industry
The FDA RF Microneedling statements are not an indictment of RF microneedling. They are a reminder that advanced medical technology requires advanced medical oversight.
When providers:
- Understand science
- Respect anatomy
- Use proper settings
- Choose appropriate patients
- Follow safety protocols
RF microneedling remains one of the most valuable tools for skin rejuvenation.
The real risk lies in:
- Under-trained operators
- Non-medical settings using medical devices
- Cookie cutter protocols
- Lack of consultation or informed consent
- Failure to understand how the device works
Education protects patients and protects our industry from unnecessary fear and misinformation.
Conclusion
RF microneedling is a powerful, versatile, and safe procedure in the right hands. The FDA recent comments were a wake-up call for some, but for experienced medical providers, they simply reaffirm the standards we have upheld for years. As medical aesthetics continues to grow, our responsibility as providers is clear. We must educate, consult thoroughly, individualize plans, and maintain mastery of the technology. That is how we continue to achieve beautiful outcomes and maintain the trust and safety of our patients.
References
FDA. (2024a). Microneedling devices: What to know. U.S. Food and Drug Administration. https://www.fda.gov
FDA. (2024b). Radiofrequency microneedling safety communication. U.S. Food and Drug Administration. https://www.fda.gov
Goldberg, D. J., & Berlin, A. L. (2019). Clinical uses of radiofrequency in dermatology. Dermatologic Surgery, 45(1), 7–15. https://doi.org/10.1097/DSS.0000000000001694
Lee, H. S., Kim, H. R., & Kim, E. J. (2020). Safety and efficacy of radiofrequency microneedling in aesthetic medicine: A review. Journal of Cosmetic and Laser Therapy, 22(3), 123–130.
Waibel, J. S., & Rudnick, A. (2021). Combined microneedling and energy-based devices for skin rejuvenation. Lasers in Surgery and Medicine, 53(6), 748–756.